Fluindione

Generic Name: Fluindione

Brand Names: -

Drug Type: Small Molecule

Chemical Formula: C_₁₅H_₉FO_₂

CAS Number: 957-56-2

Unique Ingredient Identifier: EQ35YMS20Q

Background: Fluindione is under investigation for the treatment of Venous Thrombosis, Pulmonary Embolism, Permanent Atrial Fibrillation, and Anticoagulating Treatment on a Duration at Least 12-month-old Superior. Fluindione has been investigated for the treatment of Blood Coagulation Disorders.

Associated Conditions: -

Associated Therapies: -

Clinical Trials

Vascular CalcIfiCation and sTiffness Induced by ORal antIcoAgulation

Phase 4

Completed

Conditions: Venous Thrombosis
Pulmonary Embolism
Permanent Atrial Fibrillation
Anticoagulation Treatment at Least > or = to 12-month

Interventions: Drug: Fluindione
Drug: Rivaroxaban
Drug: Warfarin

First Posted Date: 2014-06-12

Last Posted Date: 2019-11-07

Lead Sponsor: University Hospital, Angers

Target Recruit Count: 51

Registration Number: NCT02161965

Locations: 🇫🇷
University Hospital Angers, Angers, France

Prev
1
Next

Drug Development Updates

Stay informed with timely notifications on clinical trials, regulatory changes, and research advancements related to this medication.

© Copyright 2024. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy